Kieron Hilling's family believe illegally obtained prescription drugs killed the 18-year-old. Creon, a pancreatic enzyme replacement therapy, helps digestion but stocks are desperately low.

Health analysts and generic drug manufacturers said the 20% levy from two rounds of tariffs on goods imported from China − a major supplier of medical equipment and prescription drugs for the ...

A urine drug test can quickly detect both illegal and prescription drugs in a person’s system. Doctors, sports officials, and many employers require these tests. Signs of drug use can remain in ...

A class of drugs commonly used to treat movement disorders like Parkinson’s disease and restless leg syndrome is pushing people into risky sexual behavior. Patients taking dopamine agonists say ...

Ozempic reached that high-water mark despite Canadian public and private drug plans generally declining to cover it for weight loss, an off-label use ... when it comes to prescription drugs, ...

In January, the Florida Office of Insurance Regulation asked pharmacy benefit managers -- companies that manage prescription drug plans -- to hand over highly personal data about prescriptions filled ...

Express Scripts (Cigna) offers three Medicare Part D prescription drug plans, among other services. Express Scripts Medicare Part D plans range in cost from low premiums and low copays to broad ...

Prescription drug costs will likely rise significantly as a result. Unfortunately, Congress has granted broad authority to the executive branch through legislation. Specific laws that come to mind ...

And some manufacturers have begun including this information in the labeling of new drugs. But there is no requirement for the companies to go back and gather the information for drugs already on ...

The approval for the first-line treatment of esophageal squamous cell carcinoma comes shortly after a label expansion for the drug in gastric and gastroesophageal cancers as BeiGene also pushes ...

Indivior Plc said US regulators delayed a decision on label changes intended to boost its lead product, another blow to the struggling UK maker of opioid addiction medicines. The Food and Drug ...